@misc{indiciaed917f0f109f7,
  title = {SHLD2 loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy},
  author = {Rodriguez-Berriguete, G. and Thambiayah, P. and Cicconi, A. and Machado, N. and Gotorbe, C. and Nderitu, D. and Cheng, W.-C. and Boursier, M. L. and Cerutti, A. and Grinkevich, V. and Hill, B. R. and Koler, K. and Langdon, S. A. and Majithiya, J. B. and Menon, S. and Moore, S. and Neves, J. and Palmer-Deverill, N. M. and Rajendra, E. and Roy-Luzarraga, M. and Thapa, A. and Heald, R. A. and Smith, G. C. M. and Robinson, H. M. R. and Ranzani, M. and Higgins, G. S.},
  year = {2025},
  doi = {10.1101/2025.07.04.662969},
  url = {https://www.biorxiv.org/content/10.1101/2025.07.04.662969v1},
  note = {Source identifier: 10.1101/2025.07.04.662969}
}